Abstract
The mercaptoacetyltriglycine (MAG3) chelator has been shown to stably complex technetium-99m (99mTc) for nuclear imaging and radiorhenium (186/188Re) for tumor radiation therapy studies. The bifunctional N-hydroxysuccinimidyl ester of MAG3 with S-acetyl protection (N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycinate (NHS-MAG3)) has been successfully used to covalently conjugate a MAG3 chelator to primary amine functionalized biomolecules. We describe herein a simplified synthesis of NHS-MAG3 that begins with the preparation of the N-hydroxysuccinimidyl ester of S-acetylmercaptoacetic acid (N-succinimidyl S-acetylmercaptoacetate (SATA)) from mercaptoacetic acid and is followed by the synthesis of S-acetylmercaptoacetyltriglycine from SATA, together requiring about 14 days. Finally, the synthesis of NHS-MAG3 from S-acetylmercaptoacetyltriglycine requires a further 5 days. We had earlier described a method for the preparation of MAG3-conjugated and 99mTc-radiolabeled biomolecules that required elevated temperatures during postconjugation purification. We now report a modified method for the preparation that is accomplished at room temperature and therefore applicable to temperature-sensitive biomolecules. The conjugation and radiolabeling of bovine serum albumin is used as an example. The conjugation and purification requires about 2–3 h and the radiolabeling and postlabeling purification requires about an additional 2 h.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hnatowich, D.J. et al. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J. Nucl. Med. 39, 56–64 (1998).
Liu, G. et al. Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue. Clin. Cancer Res. 12, 4958–4964 (2006).
Lei, K. et al. Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison. Nucl. Med. Biol. 23, 917–922 (1996).
Zhang, Y., Liu, N., Zhu, Z., Rusckowski, M. & Hnatowich, D.J. Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA. Eur. J. Nucl. Med. 27, 1700–1707 (2000).
Vanderheyden, J.L. et al. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl. Med. Biol. 33, 135–144 (2006).
Hjelstuen, O.K., Tonnesen, H.H., Bremer, P.O. & Verbruggen, A.M. 3′-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide. Nucl. Med. Biol. 25, 651–657 (1998).
Fritzberg, A.R., Kasina, S., Eshima, D. & Johnson, D.L. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J. Nucl. Med. 27, 111–116 (1986).
van Gog, F.B., Visser, G.W., Gowrising, R.W., Snow, G.B. & van Dongen, G.A. Synthesis and evaluation of 99mTc/99Tc-MAG3-Biotin conjugates for antibody pretargeting strategies. Nucl. Med. Biol. 25, 611–619 (1998).
Okarvi, S.M. & Jammaz, I.A. Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents. Cancer Biother. Radiopharm. 21, 49–60 (2006).
Rusckowski, M., Gupta, S., Liu, G., Dou, S. & Hnatowich, D.J. Investigations of a Tc-99m-labeled bacteriophage as a potential infection-specific imaging agent. J. Nucl. Med. 45, 1201–1208 (2004).
Duncan, R.J.S., Weston, P.D. & Wrigglesworth, R. A new reagent which may be used to introduce sulfhydryl-groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132, 68–73 (1983).
Decristoforo, C. & Mather, S.J. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide. Bioconjugate Chem. 10, 431–438 (1999).
Wang, Y., Liu, G. & Hnatowich, D.J. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules. Nat. Protocols 1, 1477–1480 (2006).
Winnard, P. Jr., Chang, F., Rusckowski, M., Mardirossian, G. & Hnatowich, D.J. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24, 425–432 (1997).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wang, Y., Liu, X. & Hnatowich, D. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with 99mTc at room temperature. Nat Protoc 2, 972–978 (2007). https://doi.org/10.1038/nprot.2007.144
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.144
This article is cited by
-
Noninvasive evaluation of PD-L1 expression in non-small cell lung cancer by immunoPET imaging using an acylating agent–modified antibody fragment
European Journal of Nuclear Medicine and Molecular Imaging (2023)
-
A Comparison of [99mTc]Duramycin and [99mTc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques
Molecular Imaging and Biology (2018)
-
99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE−/− mice
Scientific Reports (2017)
-
99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation
Scientific Reports (2016)
-
Coordination investigation of rhenium with MAG3 using LC-MS and UV spectrometer and the simple radiolabelling process
Journal of Radioanalytical and Nuclear Chemistry (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.